Clinical Trial
[Efficacy of the immunostimulant Broncho-Vaxom]
[Article in
German]
- PMID: 6379870
Item in Clipboard
Clinical Trial
[Efficacy of the immunostimulant Broncho-Vaxom]
[Article in
German]
Schweiz Med Wochenschr.
.
Abstract
In a 6-month placebo-controlled double-blind multicenter study in 230 patients with recurrent respiratory tract infections, the therapeutic efficacy of Broncho-Vaxom was demonstrated by comparing infection incidence and severity as well as antibacterial medication. Investigators and patients agreed that Broncho-Vaxom exerts a significantly greater protective effect than placebo. Reports of side effects were more frequent with placebo as compared to Broncho-Vaxom.
Similar articles
-
Clinical efficacy of Broncho-Vaxom in adult patients with chronic purulent sinusitis--a multi-centric, placebo-controlled, double-blind study.Int J Clin Pharmacol Ther Toxicol. 1989 Nov;27(11):530-4. Int J Clin Pharmacol Ther Toxicol. 1989. PMID: 2693373 Clinical Trial.
-
[Effectiveness of Broncho-Vaxom in prevention of recurrent upper respiratory tract infection in children].Pol Merkur Lekarski. 2005 Nov;19(113):625-9. Pol Merkur Lekarski. 2005. PMID: 16498798 Clinical Trial. Polish.
-
[The use of broncho-vaxom preparation in clinical practice].Pol Merkur Lekarski. 2003 May;14(83):457-8. Pol Merkur Lekarski. 2003. PMID: 12939827 Review. Polish.
-
[Clinical evaluation of broncho-vaxom efficiency].Pol Tyg Lek. 1991 May 27-Jun 3;46(22-23):422-3. Pol Tyg Lek. 1991. PMID: 1669081 Polish.
-
Bacterial immunostimulants--mechanism of action and clinical application in respiratory diseases.Pneumonol Alergol Pol. 2008;76(5):353-9. Pneumonol Alergol Pol. 2008. PMID: 19003766 Review.
Cited by
-
Inhibition of spontaneous pulmonary metastases of Lewis lung carcinoma by oral treatment with Respivax and Broncho-Vaxom.Cancer Immunol Immunother. 1991;33(5):307-13. doi: 10.1007/BF01756595. Cancer Immunol Immunother. 1991. PMID: 1868489 Free PMC article.
-
OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review.World J Pediatr. 2010 Feb;6(1):5-12. doi: 10.1007/s12519-010-0001-x. Epub 2010 Feb 9. World J Pediatr. 2010. PMID: 20143206
-
Is There a Role for Immunostimulant Bacterial Lysates in the Management of Respiratory Tract Infection?Biomolecules. 2024 Oct 2;14(10):1249. doi: 10.3390/biom14101249. Biomolecules. 2024. PMID: 39456182 Free PMC article. Review.
-
Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections.Int J Chron Obstruct Pulmon Dis. 2007;2(3):335-45. Int J Chron Obstruct Pulmon Dis. 2007. PMID: 18229572 Free PMC article.
-
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2. Cochrane Database Syst Rev. 2022. PMID: 36373977 Free PMC article.